Terms: = Prostate cancer AND hCG AND Treatment
43 results:
1. Urothelial carcinoma of the prostate with raised β-hcg levels: a case report.
Sołek J; Kalwas M; Sobczak M; Dębska-Szmich S; Kupnicki P; Jesionek-Kupnicka D
J Med Case Rep; 2022 Jun; 16(1):238. PubMed ID: 35701835
[TBL] [Abstract] [Full Text] [Related]
2. Follicle-stimulating hormone promotes growth of human prostate cancer cell line-derived tumor xenografts.
Oduwole OO; Poliandri A; Okolo A; Rawson P; Doroszko M; Chrusciel M; Rahman NA; Serrano de Almeida G; Bevan CL; Koechling W; Huhtaniemi IT
FASEB J; 2021 Apr; 35(4):e21464. PubMed ID: 33724574
[TBL] [Abstract] [Full Text] [Related]
3. Tumour markers and their utility in imaging of abdominal and pelvic malignancies.
Lahoud RM; O'Shea A; El-Mouhayyar C; Atre ID; Eurboonyanun K; Harisinghani M
Clin Radiol; 2021 Feb; 76(2):99-107. PubMed ID: 32861463
[TBL] [Abstract] [Full Text] [Related]
4. Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma.
Pokharel K; Gilbar PJ; Mansfield SK; Nair LM; So A
J Oncol Pharm Pract; 2020 Jul; 26(5):1266-1269. PubMed ID: 31840564
[TBL] [Abstract] [Full Text] [Related]
5. Primary human testicular PDGFRα+ cells are multipotent and can be differentiated into cells with Leydig cell characteristics in vitro.
Eliveld J; van den Berg EA; Chikhovskaya JV; van Daalen SKM; de Winter-Korver CM; van der Veen F; Repping S; Teerds K; van Pelt AMM
Hum Reprod; 2019 Sep; 34(9):1621-1631. PubMed ID: 31398257
[TBL] [Abstract] [Full Text] [Related]
6. Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy.
Yoshimura K; Nakashima Y; Sugiyama K; Kohei N; Takizawa A
Int Braz J Urol; 2019; 45(1):38-44. PubMed ID: 29757577
[TBL] [Abstract] [Full Text] [Related]
7. [Immunoassay of nine serological tumor markers on hydrogel-based microchip].
Zubcova ZhI; Savvateeva EN; Butvilovskaia VI; Cybul'skaia MV; Chechetkin VR; Samokhina LO; Vinnitskiĭ LI; Maslennikov VV; Reznikov IuP; Zasedatelev AS; Rubina AIu
Bioorg Khim; 2013; 39(6):693-704. PubMed ID: 25696931
[TBL] [Abstract] [Full Text] [Related]
8. Gonadotropin-releasing hormone/human chorionic gonadotropin beta based recombinant antibodies and vaccines.
Talwar GP; Vyas HK; Purswani S; Gupta JC
J Reprod Immunol; 2009 Dec; 83(1-2):158-63. PubMed ID: 19854518
[TBL] [Abstract] [Full Text] [Related]
9. Hormonal and pathologic changes after chemoablation of testes with hypertonic saline solution as a treatment method alternative to orchiectomy in patients with hormone sensitive metastatic prostatic cancer.
Emir L; Sunay M; Yalbuzdağ O; Karakaya Y; Erol D
Urol Oncol; 2011; 29(2):212-7. PubMed ID: 19272797
[TBL] [Abstract] [Full Text] [Related]
10. Use of common seric tumor markers in patients with solid cancers.
Gara S; Boussen H; Ghanem A; Guemira F
Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
[TBL] [Abstract] [Full Text] [Related]
11. Human chorionic gonadotropin (hcg) interacts with lovastatin and ionizing radiation to modulate prostate cancer cell viability in vivo.
Hamed H; Mitchell C; Park MA; Hanna D; Martin AP; Harrison B; Hawkins W; Curiel DA; Fisher PB; Grant S; Yacoub A; Hagan MP; Dent P
Cancer Biol Ther; 2008 Apr; 7(4):587-93. PubMed ID: 18379195
[TBL] [Abstract] [Full Text] [Related]
12. Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment.
Yacoub A; Hawkins W; Hanna D; Young H; Park MA; Grant M; Roberts JD; Curiel DT; Fisher PB; Valerie K; Grant S; Hagan MP; Dent P
Mol Pharmacol; 2007 Jan; 71(1):259-75. PubMed ID: 17050804
[TBL] [Abstract] [Full Text] [Related]
13. Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
Shirakawa T; Gotoh A; Zhang Z; Kao C; Chung LW; Gardner TA
Urology; 2004 Mar; 63(3):613-8. PubMed ID: 15028478
[TBL] [Abstract] [Full Text] [Related]
14. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract] [Full Text] [Related]
15. [Diagnostic management of inaugurable metastases].
Penel N
Presse Med; 2003 Jun; 32(21):990-6, 1004. PubMed ID: 12876530
[TBL] [Abstract] [Full Text] [Related]
16. Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer.
Ugrinska A; Bombardieri E; Stokkel MP; Crippa F; Pauwels EK
Q J Nucl Med; 2002 Jun; 46(2):88-104. PubMed ID: 12114872
[TBL] [Abstract] [Full Text] [Related]
17. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
Canil CM; Tannock IF
Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
[TBL] [Abstract] [Full Text] [Related]
18. Human chorionic gonadotropin and inhibin induce histone acetylation in human breast epithelial cells.
Jiang X; Russo IH; Russo J
Int J Oncol; 2002 Jan; 20(1):77-9. PubMed ID: 11743645
[TBL] [Abstract] [Full Text] [Related]
19. Hormonal approach to breast cancer prevention.
Russo IH; Russo J
J Cell Biochem Suppl; 2000; 34():1-6. PubMed ID: 10762007
[TBL] [Abstract] [Full Text] [Related]
20. Antimüllerian hormone in patients with hypogonadotropic hypogonadism.
Young J; Rey R; Couzinet B; Chanson P; Josso N; Schaison G
J Clin Endocrinol Metab; 1999 Aug; 84(8):2696-9. PubMed ID: 10443662
[TBL] [Abstract] [Full Text] [Related]
[Next]
